SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (887)10/9/1998 7:19:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 1722
 
Pfizer 3rd-Q Profit Seen at 57 Cents a Share: Earnings Outlook

Bloomberg News
October 9, 1998, 5:06 p.m. ET

Expected Earnings

Pfizer Inc.'s third-quarter earnings are expected to rise to
57 cents a share, the average estimate of analysts polled by
First Call Corp. The drugmaker earned 46 cents a share in the
year-earlier period.

Time

Pfizer, maker of the impotence pill Viagra and the
antidepressant Zoloft, is expected to release earnings next week.

Behind the Numbers

Pfizer introduced two drugs this year, Viagra and the
antibiotic Trovan. It also has been able to boost sales of its
other drugs, such as the depression medicine Zoloft. Pfizer also
helps market Warner-Lambert Co.'s blockbuster drug, the
cholesterol reducer Lipitor. Introduced in 1997, Lipitor had
second-quarter sales of $533 million.

New York-based Pfizer intends to shed its medical-device
businesses to focus on more profitable drug business. Last month,
Pfizer sold two of these units for a combined $2.23 billion. It
intends to sell a third medical-device business for $1.9 billion.

What the Experts Say

''Look at the fundamentals of Pfizer,'' said Robert Flamm,
an analyst with Evergreen Asset Management, which holds about
214,000 shares of the company. ''They're a marketing machine,
they're a research machine. They know how to get products out.''

Previous Market Reaction

Pfizer rose 2 1/2 to 116 on July 9 when it reported a 38
percent increase in profit, topping estimates. Viagra had an
unprecedented U.S. introduction in April. Second-quarter sales
reached $411 million as pharmacies stocked up on the drug and
magazine and news reports helped raise demand.

Market Trend

Pfizer has dropped 19 percent to 93 since reporting second-
quarter results. In the same period, the Standard & Poor's Drugs
Index fell 5.5 percent and the Standard & Poor's 500 Index fell
15 percent.

Pfizer fell as reported U.S. Viagra sales declined. Sales
peaked at 308,631 prescriptions in the week ended May 8,
according to NDC Health Information Services, which monitors
pharmacy sales. Viagra sales seem to be increasing again, NDC
said. In the week ended Oct. 2, 190,538 Viagra prescriptions were
filled, up from 169,946 a week earlier, said NDC, a unit of
Atlanta-based National Data Corp.

--Kerry Dooley in the Princeton newsroom (609) 279-4016 /mfr



To: Anthony Wong who wrote (887)10/9/1998 7:24:00 PM
From: Anthony Wong  Respond to of 1722
 
U.S. Equity Preview: JNJ, PFE

Bloomberg News
October 9, 1998, 6:12 p.m. ET

New York, Oct. 9 (Bloomberg) -- The following is a list of
companies whose shares may move in U.S. markets Monday, Oct. 12.
U.S. Equity Preview includes news that broke after the markets
closed. The stock symbol is in parentheses after the company
name. Friday's closing prices are included.

Boeing Co. (BA): The world's largest aircraft manufacturer
said it won a 10-year, $1.2 billion contract to upgrade systems
in a U.S. Air Force fleet of 87 transport planes made by rival
Lockheed Martin Corp. (LMT). Boeing rose 1 1/8 to 32.

Chrysler Corp. (C): The automaker's third-quarter profit is
expected to rise to 87 cents a diluted share from 69 cents in the
year-earlier period, according to the average estimate of
analysts surveyed by First Call Corp. Chrysler is scheduled to
report its results at 8 a.m. New York time on Monday. Chrysler
rose 4 3/8 to 41 3/4.

Eastman Kodak Co. (EK): The world's largest photography
company is expected to earn $1.20 a share in the third quarter,
the average estimate of analysts polled by First Call. The
company earned 80 cents in the year earlier period. The company
is scheduled to release its earnings on Tuesday at 7:30 a.m. New
York time. Eastman Kodak rose 3 1/4 to 82 1/16.

Johnson & Johnson (JNJ): The medical products company's
third-quarter earnings are expected to rise to 70 cents a share,
the average estimate of analysts polled by First Call. The
company earned 63 cents in the year earlier period. The company
is scheduled to release its earnings Tuesday morning. Johnson &
Johnson rose 3/16 to 76.

Lockheed Martin Corp. (LMT): The second largest defense and
aerospace company's Astronautics unit received a $1.3 billion Air
Force contract to complete production of the Titan IV space
launch rocket line, once one of its most profitable programs, and
provide launch services. The contract, which was expected,
bankrolls the end of the Titan IV missile line as Lockheed Martin
prepares to offer the Air Force a new, cheaper fleet of rockets
called the Evolved Expendable Launch Vehicle, or the EELV for
launches after 2002. Lockheed rose 6 5/16 to 109 13/16.

Movie Gallery Inc. (MOVI): The video rental chain said it
will report a wider-than-expected third-quarter loss. The company
expects to lose 8 cents to 14 cents a share, wider than the 4-
cent average loss estimate of three analysts polled by First
Call. It had a loss of 12 cents in the year-earlier quarter.
Movie Gallery fell 3/16 to 2 13/16.

Oakwood Homes Corp. (OH): The manufactured home company said
it's buying back up to $25 million of its common stock from time
to time on the open market. Oakwood Homes rose 9/16 to 12.

Pfizer Inc. (PFE): The drugmaker's third-quarter earnings
are expected to rise to 57 cents a diluted share, the average
estimate of analysts polled by First Call. The company earned 46
cents in the year earlier period. Pfizer is expected to release
earnings next week. Pfizer rose 3 1/4 to 93.

Potlatch Corp. (PCH): The forest products company said it
had third-quarter earnings of 43 cents a share, beating the 40-
cent average estimate of analysts polled by First Call. The
company earned 48 cents in the year-earlier period. Potlatch rose
13/16 to 34 13/16.

Starbucks Corp. (SBUX): The largest gourmet-coffee chain is
expected to earn 28 cents a share for the fourth quarter ended
Sept. 28, the average estimate of analysts polled by First Call.
The company earned 22 cents in the year-earlier period. Starbucks
is scheduled to report earnings Monday. Starbucks rose 7/8 to 35.

--Jeannine DeFoe (609) 279-4096 in the Princeton newsroom/vpw